Treatment of anxiety disorders in adolescents - a feasibility study for a brief cognitive therapy for adolescent anxiety disorders

niversity of Reading0 个研究点目标入组 48 人开始时间: 2017年11月23日最近更新: 2023年1月9日

试验速览

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31023352 protocol (added 29/04/2019)

•1. Young people (aged 11-17.5 years at intake) whose primary presenting disorder is a DSM-5 diagnosis of an anxiety disorder
•2. If young people have been prescribed psychotropic medication the dosage must have been stable for two months

•1. Young people with co-morbid conditions that are likely to interfere with treatment delivery, to include an established autistic spectrum disorder or learning disabilities, suicidal intent or recurrent or potentially life-limiting self-harm (i.e., current frequency of at least once per week or self-harm that requires medical attention)
•2. Young people with a primary presenting disorder other than an anxiety disorder (including a DSM-V diagnosis of major depressive disorder (MDD))
•3. Young people identified by social services as currently ‘at risk’ due to child protection concerns

发起方

niversity of Reading